Are you a journalist looking for media resources? View Media Resources
HJF reached out to the private sector to ask for additional support to fight COVID-19. Multiple individuals and companies answered that call.
The IL-6 test will be used by researchers from HJF.
A statement from our President and CEO Dr. Joseph Caravalho.
This DOD-funded initiative will assess the role of home-based continuous biosensor data and AI analytics in addressing the global COVID-19 crisis.
The Henry M. Jackson Foundation for the Advancement of Military Medicine Honors the 2020 Heroes of Military Medicine.
Leonardo DRS Inc., announced today that it will grant up to $10,000 in contributions to support art therapy through HJF for children of military families.
On Monday, April 6, 2020 CBS Eye On Veterans published an interview about The Veterans Metrics Initiative on ConnectingVets.com.
HJF is confronting COVID-19 on two fronts: The first is to support our partners who are diligently working on finding treatments and developing a vaccine.
HJF welcomes Gail R. Wilensky, Ph.D., to the Council of Directors. Wilensky is a distinguished health economist and senior fellow at Project Hope.
HJF and USU's Joint Office of Technology Transfer was awarded the 2020 Impact Award from the Federal Laboratory Consortium for Technology Transfer (FLC).
HJF, the Uniformed Services University of the Health Sciences and Biological Mimetics, Inc. is enabling safer, more potent, and less expensive vaccine creation.
HJF has dozens of doctors, scientists, and medical researchers on its staff, but it only has one art therapist. Her name is Kristin Ramsey.
Rapid blood loss, or hemorrhaging, can be fatal. HJF's supported program, NCDMPH helped FedEx train and protect their employees.
HJF’s team of experts is ready to assist Department of Defense investigators.
This groundbreaking medical procedure possible was supported by HJF through our partnership with the Uniformed Services University of the Health Sciences.